Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure

FDA Expands Anthrax Vaccine Approval

0
Now sanctioned for adults 18 to 65 with known or suspected exposure
Opdivo (nivolumab) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma.

FDA Approves Opdivo for Advanced Renal Cell Carcinoma

0
Drug works by targeting the PD-1/PD-L1 cellular pathway
Ninlaro (ixazomib)

FDA Approves Ninlaro for Multiple Myeloma

0
New oral medication blocks certain enzymes, hindering cancer-cell growth
The U.S. Food and Drug Administration approved on Thursday a Massachusetts company's request to produce genetically modified salmon.

FDA Grants Approval for Genetically Engineered Salmon

0
Agency says it's safe to eat and doesn't need special label
Narcan (naloxone hydrochloride) nasal spray has been approved by the U.S. Food and Drug Administration to stop or reverse an overdose of opioids.

FDA Approves Narcan Nasal Spray to Counter Opioid Overdose

0
First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use
Nearly 2

FDA: Automated Endoscope Reprocessors Recalled

0
Custom Ultrasonics has history of violating federal rules for manufacturing and quality control
Cotellic (cobimetinib) in combination with another chemotherapy

FDA Approves Cotellic for Advanced Melanoma

0
For patients whose tumors express BRAF V600E or V600K mutations
A new treatment for HIV has been approved by the U.S. Food and Drug Administration. Genvoya -- a tablet containing elvitegravir

FDA Approves Genvoya to Treat HIV-1 Infection

0
Medication contains a new form of tenofovir not previously approved by the FDA
The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery

FDA Approves Expanded Use for Melanoma Drug

0
Yervoy can now be used after surgery to reduce risk of skin cancer returning
Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma lesions of the skin and lymph nodes.

FDA Approves Imlygic for Melanoma

0
Injectable drug designed to rupture and kill cancer cells